$AXON

SMITH PATRICK W sold $6.4M of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 10,000 shares of AXON ENTERPRISE, INC. (AXON) at an average of $643.79 ($626.78–$662.70, $6.44M total) across 26 trades on 2026-07-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Jul 9, 2026, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around Axon, but without any accompanying earnings, guidance, legal, or product catalyst, the decision value is limited.

02

Market read

A new, primary-source insider sale disclosure for Axon, with 10b5-1 pre-arrangement noted, implying routine execution rather than new negative information.

03

What to watch

The filing does not disclose reasons for the sale, and the net holdings after the transaction remain very large (3.04M shares), which can mute the signal.

Relevance 5/10Novelty 6/10Timing: after-hours, new SEC Form 4 disclosure filed 2026-07-09

Background

The filing is an SEC Form 4 insider transaction by Axon’s CEO, reported as an open-market sale executed across 26 trades.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon CEO Smith Patrick W sold about 10,000 shares in an open-market transaction totaling $6.44M, per a fresh SEC Form 4 filed today.

Expected impact

Likely limited immediate price impact; any reaction should be modest unless accompanied by other company-specific news.

Evidence & confidence

The article provides a primary-source Form 4 with transaction size and pricing range, but no accompanying operational or guidance change. The presence of a 10b5-1 plan suggests routine execution rather than new negative information.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be purely liquidity-driven and scheduled under a 10b5-1 plan, so it should not be treated as a bearish fundamental signal.

Key entities

  • AXON ENTERPRISE, INC.

    Subject of the Form 4 insider sale by its CEO.

  • SMITH PATRICK W

    Chief Executive Officer who sold shares totaling $6.44M.

Related articles

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12